J. Goldman & Co LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$135,000
-91.5%
54,000
-85.6%
0.01%
-90.8%
Q3 2022$1,581,000
+151.4%
374,563
+824.8%
0.08%
+216.7%
Q2 2021$629,000
-46.7%
40,500
-37.9%
0.02%
-61.3%
Q4 2017$1,181,000
+73.2%
65,263
+198.3%
0.06%
+51.2%
Q2 2015$682,00021,8760.04%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders